Solid organ transplantation for patients with end organ failure is a well-established, life-saving and life-changing treatment. People with diabetes are particularly prone to developing end stage renal disease, and transplantation is shown to improve quality and quantity of life.

Amongst people who do not have diabetes, the development of diabetes after solid organ transplantation occurs in 10-40% of recipients, and is a marker for increased mortality and morbidity (including graft loss) after transplantation.

Quality in Care Diabates Programme 2020

Nomination categories;

• Oustanding educator in Diabetes
• Diabetes professional of the Year
• The People's Award

Deadline for nominations 21 August 2020

Visit  www.qualityincare.org/diabetes to nominate

Related Resources

ABCD is pleased to announce the launch of the ABCD International Do-It-Yourself Artificial Pancreas System (DIY APS) audit and would like to invite you to take part.

We may have passed the initial peak of Covid-19, but we are only starting to understand the impact of Covid-19 on people living with diabetes.  

Sadly, almost a third of those who died during the pandemic in the UK had diabetes. Data from NHS England identified that those with Type 1 and Type 2 diabetes had a 3.5- and 2- fold increased risk of excess death, respectively. Many unanswered questions remain.

The use of FreeStyle Libre by people with Type 1 Diabetes in the UK is associated with significantly improved glycaemic control and Hypoglycaemic awareness as well as reduced Diabetes distress and few hospital admissions

Those whom we know about as of August 2023

Those whom we know about as of August 2022

Those whom we know about as of April 2022

Due to COVID-19, the 2020 ABCD Regional Meetings in Yorkshire and the Midlands, the DTN Meeting and the ABCD Conference will be delivered as virtual events. We will update the website with further details as soon as they are available. We are currently assessing options for the Consultant Development Course.

Insulin Safety Week 2020 will take place across the UK and Ireland, raising awareness in a bid to reduce insulin errors among healthcare professionals.